18-76878123-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001306089.2(ZNF236):āc.955A>Gā(p.Ser319Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,612,382 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001306089.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF236 | NM_001306089.2 | c.955A>G | p.Ser319Gly | missense_variant | 7/31 | ENST00000320610.14 | NP_001293018.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF236 | ENST00000320610.14 | c.955A>G | p.Ser319Gly | missense_variant | 7/31 | 1 | NM_001306089.2 | ENSP00000322361 | P1 | |
ZNF236 | ENST00000253159.12 | c.949A>G | p.Ser317Gly | missense_variant | 7/31 | 1 | ENSP00000253159 | |||
ZNF236 | ENST00000543926.6 | c.949A>G | p.Ser317Gly | missense_variant, NMD_transcript_variant | 7/32 | 1 | ENSP00000444524 | |||
ZNF236 | ENST00000579322.1 | n.1227A>G | non_coding_transcript_exon_variant | 6/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152264Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 248950Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 135020
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1460118Hom.: 1 Cov.: 30 AF XY: 0.0000220 AC XY: 16AN XY: 726346
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74400
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at